диссертации / 54

131

157.Karaca M., Kocoglu H., Gocmen A. Comparison of lornoxicam with thamadol in patient-control analgesia after gynecological surgery // Eur. J. Gynecol. Oncol.- 2006; 27:78-80.

158. Kassis A. Antidepressant to treatment specific low back pain // Am. Fat Physician

– 2008 – vol. 78. P. 51-52.

159.Lampert B.A. Interventional treatment of low back pain / B.A. Lampert // Mo. Med. -2007 Nov-Dec. Vol. 104 (6). - P. 496-500; quiz 500-1.

160.Lidgren L. The Bone and Joint Decade 2000-2010 / L. Lidgren // Bull. World Health Organ. 2003. - Vol. 81 (9). - P. 629.

161.Lindgren P, Geborek P, Kobelt G. Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden. Int J Technol Assess Health Care. 2009 Apr;25(2):181-9. Epub 2009 Mar 31.

162.Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.JL. Global Burden of Disease and Risk Factors. Washington: World Bank; 2006. Chapter 1.

163.Lotters F., Burdorf A. Prognostic factors for duration of sickness absence due to musculoskeletal disorders.// Clin J Pain. 2006 - Vol. 22. - N. 2. — P. 212-221.

164.Malanga G., Wolff E. Evidence – informed management of chronic low back pain with trigger point injections.// Spine J. – 2008. – Vol. 8 – P. 243-252

165.Masuda K. Biological repair of the degenerated intervertebral disc by injections of growth factors.// Eur. Spine J. – 2008. – Vol. 18 – P. 441-451

166.Matsudoura K., Seichi A., KunogiJ., et al The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis.// Spine. - 2009. - Vol. 34 - P. 115 -120

167.McGhan WF, Rowland CR, Bootman JL. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services. Am J Hosp Pharm. 1978 Feb;35(2):133-40.

168.Miyamoto, M. Epidemiological study of low back pain and occupational risk factors among taxi drivers / M. Miyamoto , S. Konno, Y. Gembun // Ind. health. —

2008. Vol. 46, № 2. - P. 7-112.

132

169.Murray C.J., Lopez A.D. The utility of DALYs for public health policy and research: a reply.// Bull World Health Organ. 1997;75(4):377-81.

170.Peng, P. STOPPAIN Investigation Group Challenges in accessing multidisciplinaiy pain treatment facilities in Canada / P. Peng, M. Choiniere, D. Dion // Can. j. anaesth. 2007. - Vol. 54, № 12. - P. 84-977.

171.Raspe H. Management of chronic low back pain in 2007-2008.// Curr

OpinRheumatol. – 2008. – Vol. 20. – P.276-281

172. Ritzwoller D. P., Gounse L., Shetterly S., Rubler D. The association of comorbidities utiliration and cost of patients identified with low back pain. // BWC Musculoskelet Disord. – 2006. – Vol.7 – P. 72-74

173.Rosenberg S.K., Grabinsky A., Kooser C., Boswell M.V. Effectiveness of transforaminal epidural steroid injection in low back pain: a one-year experience.// Pain Physician. Jul 2002. - Vol. 5. - N.3 - P 266-270.

174.Sarbu A., RadubseuS., Bowchard S. On set of analgesic effect and plasma levels of controlled – release tramadol 200-mg tablets in patients wilk acute low back pain.// J. Opoid Manag. – 2008. – Vol. 4 – P. 285-292

175.Saunders C. Quality of life assessments may help some patients / C. Saunders, M. Baum , L. Fallowfield // BMJ. 1998. - Vol.317. -P.147-149

176.Schmidt C., Raspe H., Pfingsten M. et al. Back pain in the German adult population // Spine. – 2007. –Vol. 37. – № 18. – P. 2005-2011.

177.Schnitter T.J., Ferraro A. A comprehensive reviewof clinical trials on the efficacy and sofety of drugs for the treatment of low back pain.// J. Pain Symptom Manage. - 2004. - Vol. 28 - P. 72-95

178.Schofferman J., Maranee D. Evidence - informed management of chronic low back pain with opiod analgesies.// Srine J. - 2008. - Vol. 8 - P. 185-194

179.Sharma V.K., Sethuraman G., Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India. // J Postgrad Med. 2001 Apr-Jun;47(2):95-9.

133

180.Sherman KJ, Cherkin DC, Erro J, Miglioretti DL, Deyo RA. Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. // Ann Intern Med. 2005 Dec 20;143(12):849-56.

181.Smith B.H., Penny K.I., et al. The Chronic Pain Grade questionnaire: Validation and reliability in postal research. Pain. 1997; 71: 141-147.

182.Spivey W.H. Intraosseous infusions. J Pediatr.- 1987.- Nov.-V 111.- № 5.-P.639- 643.

183.Tavafian, S. S. Low back pain education and short term quality of life: a randomized trial / S. S. Tavafian, A. Jamshidi, K. Mohammad // BMC musculoskelet dis-ord. 2007. - Vol. 28. - P. 8-21.

184.User’s Manual for the SF-36v2™ Health Survey, 3th Edition. Lincoln RI: Quality

Metric Incorporated, 2009.

185.Van den Hoogen H.J., Koes B.W., van Eijk J. The course of low back pain in general practice: a one year follow up study // Ann Rheum Dis.–1998.–№57. – P13-19.

186.Van Tulder M., Koes B. Low back pain and sciatica (chronic).Clin Evid., 2003, 10,1359-1376.

187.Veillette, Y. The treatment of chronic pain in Quebec: a study of hospital-based services offered within anesthesia departments / Y. Veillette, D. Dion, N. Altier // Can. j. anaest. 2005. - Vol. 52, № 6. – P. 6-600.

188.Waddell G. The Back Pain revolution ed. By G. Waddell. 2nd ed. Elsevier Edenburgh. - 2004. - P. 221-239

189.Wall P., Melzack R. Textbook of Pain, 4th ed.. – 1999. – Churchill Livingstone. – 1143–1153

190.Walsh T.L., Hanscom B., Lurie J.D., et al. Is a condition-specific instrument for patients with low back pain/leg symptoms really necessary? The responsiveness of the Oswestry Disability Index, MODEMS, and the SF-36. Spine 2003;28:607-15.

191.Wasan A.D., Davar G., Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain.// Pain. - Oct 2005.-Vol. 117.-N. 3.-P 450-461.

134

192.Waxman S. E., Tripp D.A., Flamenban R. The mediating role of depression and negative parther responses in chronic low back pain and relationship satiafaction. // J. Pain – 2008 – Vol. 9 – P. 434-442

193.Weiner D. K., Kim Y. S., Bonino P., Wang T. Low back pain in older adults: are we utilizing heaithcare resources wisely? // Pain Med. – 2006. – Vol. 7 – P. 143150

194.Woolf A.D. Bone and joint decade report: moving together beyond the decade. Preface // Best Pract Res Clin Rheumatol. -2012.- Apr;26(2):167-8.

135

ПРИЛОЖЕНИЕ

136

ПРИЛОЖЕНИЕ 1

137

ПРИЛОЖЕНИЕ 2

Анкета для клинико-экономического анализа историй болезни

6.Диагноз

7.Продолжительность заболевания

10.Количество госпитализаций за год (включая эту)

11.Пребывание на больничном листе

12.Данные неврологического осмотра:

При поступлении

При выписке

138

ПРИЛОЖЕНИЕ 3

139

140

ПРИЛОЖЕНИЕ 4